Skip to content
Drug recall · FDA · Published September 22, 2017

Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI)

Boehringer Ingelheim recalls Mobic 15mg tablets with incorrect or missing package inserts. Affected lots may not have proper instructions for safe use.

🇺🇸 FDA recall #D-0007-2018DrugBoehringer Ingelheim ›
Take action

Contact the company & request your remedy

Recalling firmBoehringer Ingelheim Pharmaceuticals, Inc.39 Briar Ridge Rd. · Danbury, CT 06810
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Boehringer Ingelheim is recalling Mobic 15mg tablets that were packaged with an incorrect or missing package insert. This could lead to improper use if the patient doesn't have the correct instructions. Read more at govinfonow.com/recall/41174-mobic-15mg-tablets-recall-incorrect-package-insert-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/41174-mobic-15mg-tablets-recall-incorrect-package-insert-hazard · Updated October 7, 2026 · FDA enforcement record: FDA #D-0007-2018

Cite this page

“Mobic 15mg Tablets Recall: Incorrect Package Insert Hazard.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41174-mobic-15mg-tablets-recall-incorrect-package-insert-hazard. Based on FDA recall #D-0007-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0007-2018%22&limit=1).

Why it’s dangerous

The package insert is critical for safe use of the medication. Without the correct instructions, patients may not understand how to take the drug properly, potentially leading to incorrect dosing or side effects.

Who’s affected

Prescription patients who received Mobic 15mg tablets with the incorrect package insert. Those who have the specific lot number 754037 are most at risk.

How to tell if you have this one

Check the product label for the lot number 754037. The product is a 100-count bottle of Mobic 15mg tablets, prescription-only, distributed by Boehringer Ingelheim.

  • Brand
    Boehringer Ingelheim
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Package Insert

    Verify if your Mobic 15mg tablets have the correct package insert. If missing or incorrect, contact the manufacturer.

✎ GovInfoNow

Questions people ask

Is this recall dangerous?

The recall is for an incorrect or missing package insert, which could lead to improper use. However, the hazard is low risk as it does not involve immediate injury or death.

What should I do if I have the recalled product?

Check if your Mobic 15mg tablets have the lot number 754037. If so, contact Boehringer Ingelheim for instructions.

How can I confirm if my product is affected?

Look for the lot number 754037 on the product label. The product is a 100-count bottle of Mobic 15mg tablets, prescription-only, distributed by Boehringer Ingelheim.

Take action

Contact Boehringer Ingelheim

We’ve drafted a message you can send Boehringer Ingelheim to request your refund or repair — edit it as you like.

Subject: Recall D-0007-2018 — Boehringer Ingelheim Boehringer Ingelheim

Hello,

I own a Boehringer Ingelheim that is covered by recall D-0007-2018 from Boehringer Ingelheim.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0007-2018 (September 22, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0007-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA